findmyKOL

Martha Pavlakis, MD

Basic profile

Beth Israel Deaconess Medical Center

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding2004–2008

Martha Pavlakis is a Nephrology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 200 publications with 4,684 citations (h-index 36); ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
200publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,684citations

Total citations across indexed works.

36h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2004–2008

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

110 Francis St
7th Floor
Boston, MA 022155501

Telephone

617-632-9700

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    30.5%
    Beta blocker11.1%
    Metoprolol Succinate35%Carvedilol35%Labetalol Hcl20%Metoprolol Tartrate10%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)5.5%
    Losartan Potassium100%
    Part D14 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    29.9%
    Corticosteroid21.7%
    Prednisone100%
    Part D53 patients
    Proton pump inhibitor5%
    Omeprazole58%Pantoprazole Sodium42%
    Part D<11 patients

    + 2 more classes in this area

  • Cancer & immunology

    18%
    Calcineurin inhibitor14.9%
    Tacrolimus93%Envarsus Xr7%
    Part D<11 patients
    Kinase inhibitor1.8%
    Sirolimus100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)97.9% facility · 2.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20042008 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”